127 related articles for article (PubMed ID: 38103462)
1. Efficacy of probiotic treatment as post-exposure prophylaxis for COVID-19: A double-blind, Placebo-Controlled Randomized trial.
Wischmeyer PE; Tang H; Ren Y; Bohannon L; Jiang D; Bergens M; Ramirez ZE; Andermann TM; Messina JA; Sung JA; Jensen D; Jung SH; Artica A; Britt A; Bush A; Johnson E; Lew MV; Winthrop H; Pamanes C; Racioppi A; Zhao AT; Wan Z; Surana NK; Sung AD
Clin Nutr; 2024 Jan; 43(1):259-267. PubMed ID: 38103462
[TBL] [Abstract][Full Text] [Related]
2. Randomised, double-blind, placebo-controlled trial of Probiotics To Eliminate COVID-19 Transmission in Exposed Household Contacts (PROTECT-EHC): a clinical trial protocol.
Tang H; Bohannon L; Lew M; Jensen D; Jung SH; Zhao A; Sung AD; Wischmeyer PE
BMJ Open; 2021 May; 11(5):e047069. PubMed ID: 33952552
[TBL] [Abstract][Full Text] [Related]
3. Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a study protocol for a randomised controlled trial.
Lee BB; Toh SL; Ryan S; Simpson JM; Clezy K; Bossa L; Rice SA; Marial O; Weber G; Kaur J; Boswell-Ruys C; Goodall S; Middleton J; Tudehope M; Kotsiou G
BMC Urol; 2016 Apr; 16():18. PubMed ID: 27084704
[TBL] [Abstract][Full Text] [Related]
4. Infant behavioral state and stool microbiome in infants receiving Lactocaseibacillus rhamnosus GG in formula: randomized controlled trial.
Shulman RJ; Chichlowski M; Orozco FG; Harris CL; Wampler JL; Bokulich NA; Berseth CL
BMC Pediatr; 2022 Oct; 22(1):580. PubMed ID: 36207675
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
Boulware DR; Pullen MF; Bangdiwala AS; Pastick KA; Lofgren SM; Okafor EC; Skipper CP; Nascene AA; Nicol MR; Abassi M; Engen NW; Cheng MP; LaBar D; Lother SA; MacKenzie LJ; Drobot G; Marten N; Zarychanski R; Kelly LE; Schwartz IS; McDonald EG; Rajasingham R; Lee TC; Hullsiek KH
N Engl J Med; 2020 Aug; 383(6):517-525. PubMed ID: 32492293
[TBL] [Abstract][Full Text] [Related]
8. Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial.
Grau-Pujol B; Camprubí D; Marti-Soler H; Fernández-Pardos M; Guinovart C; Muñoz J
Trials; 2020 Jul; 21(1):688. PubMed ID: 32727613
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects elicited by the probiotic Lacticaseibacillus rhamnosus GG in children with atopic dermatitis. The results of the ProPAD trial.
Carucci L; Nocerino R; Paparo L; De Filippis F; Coppola S; Giglio V; Cozzolino T; Valentino V; Sequino G; Bedogni G; Russo R; Ercolini D; Berni Canani R
Pediatr Allergy Immunol; 2022 Aug; 33(8):e13836. PubMed ID: 36003050
[TBL] [Abstract][Full Text] [Related]
10. Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial.
Lother SA; Abassi M; Agostinis A; Bangdiwala AS; Cheng MP; Drobot G; Engen N; Hullsiek KH; Kelly LE; Lee TC; Lofgren SM; MacKenzie LJ; Marten N; McDonald EG; Okafor EC; Pastick KA; Pullen MF; Rajasingham R; Schwartz I; Skipper CP; Turgeon AF; Zarychanski R; Boulware DR
Can J Anaesth; 2020 Sep; 67(9):1201-1211. PubMed ID: 32383125
[TBL] [Abstract][Full Text] [Related]
11. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
Guo Q; Goldenberg JZ; Humphrey C; El Dib R; Johnston BC
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD004827. PubMed ID: 31039287
[TBL] [Abstract][Full Text] [Related]
12. Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial.
Hojsak I; Snovak N; Abdović S; Szajewska H; Misak Z; Kolacek S
Clin Nutr; 2010 Jun; 29(3):312-6. PubMed ID: 19896252
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
15. Effect of Lactobacillus rhamnosus GG Administration on Vancomycin-Resistant Enterococcus Colonization in Adults with Comorbidities.
Doron S; Hibberd PL; Goldin B; Thorpe C; McDermott L; Snydman DR
Antimicrob Agents Chemother; 2015 Aug; 59(8):4593-9. PubMed ID: 26014940
[TBL] [Abstract][Full Text] [Related]
16. Probiotics for Reduction of Examination Stress in Students (PRESS) study: A randomized, double-blind, placebo-controlled trial of the probiotic Lacticaseibacillus rhamnosus HN001.
Slykerman RF; Li E; Mitchell EA
PLoS One; 2022; 17(6):e0267778. PubMed ID: 35675229
[TBL] [Abstract][Full Text] [Related]
17. Lactobacillus casei strain GG in the treatment of infants with acute watery diarrhea: a randomized, double-blind, placebo controlled clinical trial [ISRCTN67363048].
Salazar-Lindo E; Miranda-Langschwager P; Campos-Sanchez M; Chea-Woo E; Sack RB
BMC Pediatr; 2004 Sep; 4():18. PubMed ID: 15345099
[TBL] [Abstract][Full Text] [Related]
18. Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a randomised controlled trial.
Toh SL; Lee BB; Ryan S; Simpson JM; Clezy K; Bossa L; Rice SA; Marial O; Weber GH; Kaur J; Boswell-Ruys CL; Goodall S; Middleton JW; Tuderhope M; Kotsiou G
Spinal Cord; 2019 Jul; 57(7):550-561. PubMed ID: 30814670
[TBL] [Abstract][Full Text] [Related]
19. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
20. Probiotics and respiratory and gastrointestinal tract infections in Finnish military conscripts - a randomised placebo-controlled double-blinded study.
Kalima K; Lehtoranta L; He L; Pitkäniemi J; Lundell R; Julkunen I; Roivainen M; Närkiö M; Mäkelä MJ; Siitonen S; Korpela R; Pitkäranta A
Benef Microbes; 2016 Sep; 7(4):463-71. PubMed ID: 27048835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
